Dr. Sung Chul Kim co-founded LSK BioPharma in 2005 to conduct business development and regulatory consulting as a bridge for the healthcare industry in South Korea and North America. Dr. Kim is the President, CEO, and sits on the Board of Directors.
Dr. Kim brings 26 years of drug development experience covering areas such as pharmaceutical product development, non-clinical studies, clinical trials, cGMP manufacturing, Korean and US regulatory affairs, as well as business development. His academic experience includes a Ph.D. in Pharmaceutics, a M.S. in Pharmaceutics and a B.S. in Pharmacy from Sungkyunkwan University.